Skip to content

ARCTURUS THERAPEUTICS HOLDINGS INC.

ARCT

CIK 0001768224

← back to feed
Revenue (TTM)
$76.9M
−46.1% YoY Q1 May 2026
Net Income (TTM)
−$63.67M
+18.7% YoY Q1 May 2026
EPS Diluted (TTM)
−$2.30
+20.0% YoY Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
-96.1%
Q1 May 2026
Net Margin
-82.8%
Q1 May 2026
Free Cash Flow (TTM)
−$97.08M
Q1 May 2026
Cash
$211.38M
Q1 May 2026
Total Debt
$75.66M
Q1 May 2026
Shares Outstanding
28.42M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings